
Latest 'delegated regulation' of the Falsified Medicines Directive is promulgated

Latest 'delegated regulation' of the Falsified Medicines Directive is promulgated

Acsis polls industry sentiment; TraceLink touts doubling of revenue

IMS Health/Ego Zender survey of CIOs finds short tenures and evolving skill sets

Accenture, Cognizant and PwC more or less tie for their capabilities in life sciences sales & marketing consulting, says IDC

PDI had been struggling with a customer dataset of millions of physicians, nurse practitioners, pharmacists and other healthcare professionals (HCPs)

Zephyr Illuminate pools disparate data for predictive analytics for commercial operations

How taking an aggressive and comprehensive approach in 2015 can save millions in 2023

Achieving Compliance with Ever-Changing Requirements


First new-product release since the IMS Health-Cegedim Relationship Management acquisition

New IT tools are propelling a more focused approach to product launch

New advisory capability for field reps will be built into Veeva's CRM

Combining high-quality patient-support services with comprehensive and continually updated analytics results in better outcomes

Company wins $10 million in venture capital as it lines up key life sciences service providers

Identity Hub expedites access to regulated content in prescribing and other commercial applications

Collaboration with American College of Cardiology could result in new health-outcomes results

Cloud computing opens a new array of benefits--and challenges--to data-sharing

Identity Management

Contracts with payers that contain terms based on outcomes can highlight a drug's value

MDM practices are moving far beyond compliance concerns

The Commercial Cloud integrates more pharma-rep activities into a common, cloud-based system

Marketers will be able to track individual pharmacy inventories, dispensing trends

Setting a foundation for long-term success: How the pharmaceutical industry can transform Big Data into actionable insight

Researchers suggest that the surge in analysis of large data sets may have limitations for understanding healthcare patterns

Enhanced reuse could be possible with ProEnvision system